Search

Yasuko Maeda Hatta

age ~61

from Marietta, GA

Also known as:
  • Yasuko Maeda

Yasuko Hatta Phones & Addresses

  • Marietta, GA
  • 10 Raskin Cir, Madison, WI 53719 • 608 827-8627
  • Olmsted Twp, OH

Us Patents

  • Screen For Inhibitors Of Filovirus And Uses Therefor

    view source
  • US Patent:
    20110263554, Oct 27, 2011
  • Filed:
    Nov 6, 2009
  • Appl. No.:
    13/127951
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Shinji Watanabe - Madison WI, US
    Yasuko Hatta - Madison WI, US
  • Assignee:
    WARF - Wisconsin Alumni Research Foundation - Madison WI
  • International Classification:
    A61K 31/573
    A61K 31/40
    A61K 31/438
    A61K 31/4535
    A61K 31/45
    A61K 31/395
    A61K 31/366
    A61K 31/439
    A61K 31/05
    A61K 31/405
    A61K 31/4155
    A61K 31/433
    A61P 31/14
    A61K 31/015
    A61K 31/56
    C12Q 1/70
  • US Classification:
    514181, 435 5, 514428, 514278, 514324, 514328, 514183, 514453, 514304, 514460, 514732, 514419, 514406, 514363, 514764, 514169
  • Abstract:
    The invention provides methods to identify agents useful to prevent, inhibit or treat viral infections, e.g. filovirus infections, as well as compositions having one or more agents to prevent, inhibit or treat viral infection.
  • Influenza Virus Mutants And Uses Therefor

    view source
  • US Patent:
    20220409719, Dec 29, 2022
  • Filed:
    Dec 22, 2021
  • Appl. No.:
    17/558852
  • Inventors:
    - Madison WI, US
    Yasuko HATTA - Madison WI, US
  • International Classification:
    A61K 39/145
    A61K 39/12
    C07K 14/005
    C12N 7/00
    A61K 35/76
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Immunogenic Compositions Against Influenza

    view source
  • US Patent:
    20230099147, Mar 30, 2023
  • Filed:
    May 18, 2022
  • Appl. No.:
    17/747713
  • Inventors:
    - Madison WI, US
    Yasuko HATTA - Madison WI, US
    Pamuk Bilsel - Madison WI, US
  • Assignee:
    FluGen, Inc. - Madison WI
  • International Classification:
    A61K 39/145
    C12N 7/00
    A61K 39/295
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include mutant M2 sequences, mutant BM2 sequences, and are useful in immunogenic compositions, e.g., as a quadrivalent vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Influenza Virus Vectors And Uses Therefor

    view source
  • US Patent:
    20230029543, Feb 2, 2023
  • Filed:
    Feb 18, 2022
  • Appl. No.:
    17/675297
  • Inventors:
    - Madison WI, US
    Yasuko Hatta - Madison WI, US
    Pamuk Bilsel - Madison WI, US
    Michael J. Moser - Madison WI, US
  • Assignee:
    FluGen, Inc. - Madison WI
  • International Classification:
    A61K 39/145
    A61K 39/12
    A61K 39/00
    C12N 7/00
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. The mutant viruses disclosed herein including a mutant M2 sequence are also useful to deliver antigens to a subject, e.g., to induce an immune response to the antigen. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Influenza Virus Vectors And Uses Therefor

    view source
  • US Patent:
    20210023197, Jan 28, 2021
  • Filed:
    Nov 6, 2019
  • Appl. No.:
    16/676119
  • Inventors:
    - Madison WI, US
    Yasuko Hatta - Madison WI, US
    Pamuk Bilsel - Madison WI, US
    Michael J. Moser - Madison WI, US
  • Assignee:
    FluGen, Inc. - Madison WI
  • International Classification:
    A61K 39/145
    A61K 39/12
    A61K 39/00
    C12N 7/00
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. The mutant viruses disclosed herein including a mutant M2 sequence are also useful to deliver antigens to a subject, e.g., to induce an immune response to the antigen. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Influenza B Virus Mutants And Uses Therefor

    view source
  • US Patent:
    20200282045, Sep 10, 2020
  • Filed:
    Feb 26, 2018
  • Appl. No.:
    16/488913
  • Inventors:
    - Madison WI, US
    Yasuko Hatta - Madison WI, US
    Pamuk Bilsel - Madison WI, US
  • Assignee:
    FluGen, Inc. - Madison WI
  • International Classification:
    A61K 39/145
    C12N 7/00
    A61K 39/39
    C07K 14/005
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant BM2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Immunogenic Compositions Against Influenza

    view source
  • US Patent:
    20200254085, Aug 13, 2020
  • Filed:
    Feb 26, 2018
  • Appl. No.:
    16/488906
  • Inventors:
    - Madison WI, US
    Yasuko HATTA - Madison WI, US
    Pamuk Bilsel - MADISON WI, US
  • Assignee:
    FluGen, Inc. - Madison WI
  • International Classification:
    A61K 39/145
    A61K 39/295
    C12N 7/00
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include mutant M2 sequences, mutant BM2 sequences, and are useful in immunogenic compositions, e.g., as a quadrivalent vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
  • Influenza Virus Mutants And Uses Therefor

    view source
  • US Patent:
    20200061182, Feb 27, 2020
  • Filed:
    Mar 28, 2019
  • Appl. No.:
    16/368315
  • Inventors:
    - Madison WI, US
    Yasuko HATTA - Madison WI, US
  • International Classification:
    A61K 39/145
    A61K 35/76
    C12N 7/00
    C07K 14/005
    A61K 39/12
  • Abstract:
    Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Get Report for Yasuko Maeda Hatta from Marietta, GA, age ~61
Control profile